Thomastown, Australia

Matthias Pelzing


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matthias Pelzing: Innovator in Coagulation Disorders

Introduction

Matthias Pelzing is a notable inventor based in Thomastown, Australia. He has made significant contributions to the field of medicine, particularly in the area of coagulation disorders. With a total of three patents to his name, Pelzing's work has the potential to impact many lives.

Latest Patents

Pelzing's latest patents include innovative methods for preparing modified von Willebrand Factor. This invention provides modified von Willebrand Factor molecules, methods for their preparation, and various uses thereof. Additionally, the invention offers pharmaceutical compositions aimed at treating coagulation disorders. His work in this area is crucial for developing effective treatments for patients suffering from these conditions.

Career Highlights

Matthias Pelzing is currently associated with CSL Behring Lengnau AG, a company known for its focus on biopharmaceuticals. His role at the company allows him to apply his expertise in developing solutions for coagulation disorders. Pelzing's dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Pelzing has collaborated with esteemed colleagues such as Stefan Schulte and Hans-Wilhelm Beltz. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medicine.

Conclusion

Matthias Pelzing's contributions to the field of coagulation disorders through his patents and collaborations highlight his commitment to medical innovation. His work continues to pave the way for advancements in treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…